News ID: 192870
Published: 0858 GMT 16 May 2017

Researchers find a new target for antidepressants

Researchers find a new target for antidepressants

Researchers at Columbia University Medical Center found the brain's mu opioid receptors are responsible for the depression-relieving effects of tianeptine.

Tianeptine is an antidepressant also used to relieve pain without causing withdrawal symptoms, has approved for use in Europe, Asia and South America, UPI wrote.

The drug works as well as selective serotonin reuptake inhibitors, or SSRIs, but little was known about exactly how tianeptine worked to alleviate depression symptoms.

The researchers' findings, detailed in a study published in Neuropsychopharmacology, that tianeptine fails to produce an antidepressant effect in mice when the mu opioid receptor is blocked with antagonists or genetically removed.

A metabolite of tianeptine known as MCS, is the drug's active ingredient and may be used to create more effective versions of the antidepressant because, currently, medication adherence is low and patients need to take three doses a day.

Morphine is the best known agonist of the mu opioid receptor, however, morphine is often abused because it is an effective pain reliever.

Researchers found that tianeptine also reduces pain but does not cause tolerance or withdrawal symptoms like morphine.

Rene Hen, professor of neuroscience and pharmacology at Columbia University, said, "Our work highlights a novel way to provide antidepressant treatment and provides a new avenue for the development of potentially more effective antidepressants that offer relief to patients who do not respond to current treatments.”

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/1862 sec